lobbying_activities: 2203054

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2203054	654937b7-e7cc-411d-a8f9-eaf68a9d8be1	Q3	U.S. CHAMBER INSTITUTE FOR LEGAL REFORM	51172	U S CHAMBER INSTITUTE FOR LEGAL REFORM	2018	third_quarter	HCR	S. 974, Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2017 Proposed regulation regarding labeling changes for approved drugs and biological products (78 Fed. Reg. 67,985-67,999, November 13, 2013) Various issues relating to drug and medical device preemption	Federal Communications Commission (FCC),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Securities & Exchange Commission (SEC),SENATE		7630000	0	0	2018-10-22T07:18:06.260000-04:00